National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

6.6 Major clinical issues with anxiety disorders and stimulant (including methamphetamine) use

prev pageTOC |next page

Table of contents

6.6.1 Effects of stimulants on anxiety disorders

6.6.2 Interactions between stimulants and therapeutic agents for anxiety disorders

6.6.3 Management approaches to comorbid anxiety disorders and stimulant use

prev pageTOC |next page